Cited by 33Diabetes Management and ResearchDiabetes Treatment and ManagementDiabetes Management and Education

Self-monitoring of blood glucose in association with glycemic control in newly diagnosed non-insulin-treated diabetes patients: a retrospective cohort study

Open access
Sia, Hon-Ke, Kor, Chew-Teng, Tu, Shih-Te, Liao, Pei-Yung, Wang, Jiun-Yi·2021·Scientific Reports

Abstract

The benefits of self-monitoring of blood glucose (SMBG) on glycemic control among type 2 diabetes (T2DM) patients not receiving insulin remains controversial. This study aimed to examine the association between SMBG and glycemic control in these patients. This retrospective longitudinal study enrolled 4987 eligible patients from a medical center in Taiwan. Data were collected from electronic medical records at 0 (baseline), 3, 6, 9, and 12 (end-point) months after enrollment. Patients were assigned to the early SMBG group or to the non-user group depending on whether they performed SMBG at baseline. Differences in glycated hemoglobin (HbA1c) reduction between groups at each time-point were assessed using SMBG group-by-time interaction in generalized estimating equations models, which were established using backward elimination method for multivariate regression analysis. Subgroup analyses for patients using non-insulin and insulin secretagogues were performed additionally. The estimated maximal difference in HbA1c reduction between groups (early SMBG users vs. non-users) was 0.55% at 3 months. Subgroup analyses showed maximal differences of 0.61% and 0.52% at 3 months in the non-insulin and insulin secretagogues groups, respectively. SMBG group-by-time interaction was statistically significant at 3 months and lasted for 12 months. The finding suggests that performing SMBG at disease onset was positively associated with better glycemic control in newly diagnosed non-insulin-treated T2DM patients, regardless whether non-insulin secretagogues or insulin secretagogues were used.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-021-81024-x

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The reduction in glycated haemoglobin from blood glucose monitoring in non-insulin-treated type 2 diabetes is particularly seen if monitoring is started at diagnosis.

    “particularly if it is started at diagnosis6”

    From Blood glucose monitoring devices: current considerations (2023) · cites this paper as [6]

    The Results (Association between SMBG and changes in HbA1c; page unavailable) report greater HbA1c reduction among newly diagnosed patients who monitored at baseline than among early non-users. But this retrospective study describes an association, not a proven reduction caused by monitoring, and does not establish that starting at diagnosis works better than starting later. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sia, H.-K., Kor, C.-T., Tu, S.-T., Liao, P.-Y., & Wang, J.-Y.
Affiliations
  • Asia University (TW)
  • Changhua Christian Hospital (TW)
Corresponding author
Wang, Jiun-Yi
Venue
Scientific Reports
Published
2021-01-13
Volume
11
Issue
1
Pages
1176-1176
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3121099789
Cited by
33
References
27
Citations by year
2026: 6 · 2025: 5 · 2024: 7 · 2023: 8 · 2022: 7
FWCI
4.11
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Changhua Christian Hospital Research Foundation (109-CCH-IRP-009)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
self-monitoring of blood glucose, glycemic control, type 2 diabetes, newly diagnosed diabetes, non-insulin-treated diabetes, HbA1c, HbA1c reduction, insulin secretagogues, disease onset
MeSH terms
Glycemic Control, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Longitudinal Studies, Male, Retrospective Studies, Taiwan, Blood Glucose Self-Monitoring

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review